Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett
Steven L Teitelbaum

Showing results (671-680 of 1,009) with videos related to

Pageof 101
Sort By:
Clinical Rheumatology|August 6, 2018
Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN studyDésirée van der Heijde, Patrick Durez, Georg Schett, et al.
Scientific Reports|June 24, 2026
Impact of personalized coaching on the use of digital health interventions for movement therapy in rheumatology: a randomized controlled trialMagdalena Binder, Alp Temiz, Paloma Palm von Alten Blaskowitz, et al.
Arthritis and Rheumatism|February 12, 2011
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosisClara Dees, Pawel Zerr, Michal Tomcik, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2011
Blockade of TNF-α rapidly inhibits pain responses in the central nervous systemAndreas Hess, Roland Axmann, Juergen Rech, et al.
Annals of the Rheumatic Diseases|January 10, 2018
Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulatorsAlexandru-Emil Matei, Christian Beyer, Andrea-Hermina Györfi, et al.
Rheumatology (Oxford, England)|September 16, 2021
Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATEMaria Antonietta D'Agostino, Georg Schett, Alejandra López-Rdz, et al.
Scientific Reports|August 21, 2021
Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse modelMarie-Lisa Hülser, Yubin Luo, Klaus Frommer, et al.
Journal of Cell Science|September 17, 2009
Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesisCordula Surmann-Schmitt, Nathalie Widmann, Uwe Dietz, et al.
Annals of the Rheumatic Diseases|May 8, 2017
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatmentYun Zhang, Ruifang Liang, Chih-Wei Chen, et al.
Lancet (London, England)|February 10, 2020
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trialChristopher T Ritchlin, Arthur Kavanaugh, Joseph F Merola, et al.
Pageof 101

Showing results (671-680 of 1,009) with videos related to

Sort By:
Pageof 101
Clinical Rheumatology|August 6, 2018
Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN studyDésirée van der Heijde, Patrick Durez, Georg Schett, et al.
Scientific Reports|June 24, 2026
Impact of personalized coaching on the use of digital health interventions for movement therapy in rheumatology: a randomized controlled trialMagdalena Binder, Alp Temiz, Paloma Palm von Alten Blaskowitz, et al.
Arthritis and Rheumatism|February 12, 2011
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosisClara Dees, Pawel Zerr, Michal Tomcik, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2011
Blockade of TNF-α rapidly inhibits pain responses in the central nervous systemAndreas Hess, Roland Axmann, Juergen Rech, et al.
Annals of the Rheumatic Diseases|January 10, 2018
Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulatorsAlexandru-Emil Matei, Christian Beyer, Andrea-Hermina Györfi, et al.
Rheumatology (Oxford, England)|September 16, 2021
Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATEMaria Antonietta D'Agostino, Georg Schett, Alejandra López-Rdz, et al.
Scientific Reports|August 21, 2021
Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse modelMarie-Lisa Hülser, Yubin Luo, Klaus Frommer, et al.
Journal of Cell Science|September 17, 2009
Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesisCordula Surmann-Schmitt, Nathalie Widmann, Uwe Dietz, et al.
Annals of the Rheumatic Diseases|May 8, 2017
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatmentYun Zhang, Ruifang Liang, Chih-Wei Chen, et al.
Lancet (London, England)|February 10, 2020
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trialChristopher T Ritchlin, Arthur Kavanaugh, Joseph F Merola, et al.
Pageof 101